Skip to content

Envoy Medical COCH Asset write-downs

Asset write-downs at other companies

Stryker logo
StrykerSYK
$0-100%
Schlumberger
 logo
Schlumberger SLB
$82.75M+104%
Phillips 66 logo
Phillips 66PSX
$8M-69.2%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$36M+20.0%
Cencora logo
CencoraCOR
$0
Equinix, Inc. logo
Equinix, Inc.EQIX
$2M

Other financials

Income statement

See full
Revenue$39.0K-15.2%
Gross profit-$274.0K-52.2%
Operating income-$6.0M-16.7%
Net income-$4.4M+12.9%
EPS (diluted)-$0.08+72.4%

Balance sheet

See full
Cash & equivalents$25.3M+376%
Total debt$919.0K-2.8%
Total equity$10.2M+142%
Total assets$29.8M+187%

Cash flow

See full
Operating cash flow-$6.1M-62.7%
CapEx$172.0K
Free cash flow-$5.9M-28.5%

Valuation

See full
Market cap$61M+83.5%
P/S260.7×+111×

Profitability

See full
Gross margin-310.7%+31.6pp
Operating margin-9,881.2%+805pp
Net margin-9,875.6%+771pp
FCF margin-7,626.6%-652pp

Returns & leverage

See full
Return on equity328.7%
Debt / equity0.1×
Current ratio2.3×+1.2×

Where this comes from

Reported directly by Envoy Medical in its filing.

Tagged under the XBRL concept us-gaap:AssetImpairmentCharges.

The official record: Envoy Medical’s 10-K, filed March 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's asset write-downs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envoy Medical's asset write-downs?
Envoy Medical (COCH) reported asset write-downs of $0 in Q4 2024.